{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:45:50Z","timestamp":1770741950188,"version":"3.49.0"},"reference-count":46,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OTT"],"DOI":"10.2147\/ott.s317570","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T12:11:19Z","timestamp":1633003879000},"page":"4941-4960","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and Toxicity Profile of\u00a0Carfilzomib-Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A\u00a0Systematic Review"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Hassaan","family":"Imtiaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maimoona","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4607-3171","authenticated-orcid":true,"given":"Hamid","family":"Ehsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsan","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4113-3304","authenticated-orcid":true,"given":"Abdul","family":"Rafae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Y","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdur","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1952-8203","authenticated-orcid":true,"given":"Muhammad Khawar","family":"Sana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taimoor Jaffar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqraa","family":"Ansar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzammil M","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6914-7439","authenticated-orcid":true,"given":"Faiz","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41408-020-0298-1","volume":"10","author":"Zhang","year":"2020","journal-title":"Blood Cancer J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41375-019-0517-6","volume":"33","author":"Landgren","year":"2019","journal-title":"Leukemia"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1182\/asheducation-2018.1.83","volume":"2018","author":"Facon","year":"2018","journal-title":"Hematology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.3324\/haematol.2019.228684","volume":"104","author":"Engelhardt","year":"2019","journal-title":"Haematologica"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1080\/14656566.2017.1404575","volume":"18","author":"Ziogas","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1182\/blood-2014-03-563759","volume":"124","author":"Bringhen","year":"2014","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/ejh.12749","volume":"96","author":"Muchtar","year":"2016","journal-title":"Eur J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"172458","DOI":"10.1155\/2015\/172458","volume":"2015","author":"Accardi","year":"2015","journal-title":"Biomed Res Int"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.6004\/jnccn.2020.0057","volume":"18","author":"Shaji","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/j.clml.2019.09.079","volume":"19","author":"Alsina","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0297-2","volume":"10","author":"Gavriatopoulou","year":"2020","journal-title":"Blood Cancer J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1182\/blood-2012-04-422683","volume":"120","author":"Jakubowiak","year":"2012","journal-title":"Blood"},{"key":"ref13","first-page":"4533","volume":"130","author":"Jakubowiak","year":"2017","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1001\/jamaoncol.2018.5457","volume":"4","author":"Kazandjian","year":"2018","journal-title":"JAMA Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1182\/blood-2018-99-117120","volume":"132","author":"Korde","year":"2018","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jamaoncol.2015.2010","volume":"1","author":"Korde","year":"2015","journal-title":"JAMA Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1182\/blood.V128.22.1142.1142","volume":"128","author":"Roussel","year":"2016","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1182\/blood.V128.22.675.675","volume":"128","author":"Zimmerman","year":"2016","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3324\/haematol.2018.205476","volume":"104","author":"Wester","year":"2019","journal-title":"Haematologica"},{"key":"ref20","volume-title":"A Phase II Study with Carfilzomib, Cyclophosphamide and Dexamethasone (CCD) for Newly Diagnosed Multiple Myeloma","year":"2013"},{"key":"ref21","first-page":"234","volume":"2","author":"Larocca","year":"2018","journal-title":"HemaSphere"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1182\/blood.V124.21.4739.4739","volume":"124","author":"Bensinger","year":"2014","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.clml.2017.05.009","volume":"17","author":"Boccia","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/leu.2017.327","volume":"32","author":"Bringhen","year":"2018","journal-title":"Leukemia"},{"key":"ref25","first-page":"589","volume":"2","author":"Chen","year":"2018","journal-title":"HemaSphere"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1182\/blood-2019-127992","volume":"134","author":"Yong","year":"2019","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1158\/1078-0432.CCR-18-3642","volume":"25","author":"Leleu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1182\/blood-2015-02-626168","volume":"125","author":"Moreau","year":"2015","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/bjh.13296","volume":"169","author":"Mikhael","year":"2015","journal-title":"Br J Haematol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/j.clml.2019.09.003","volume":"19","author":"Pawlyn","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref31","first-page":"3110","volume":"130","author":"Chari","year":"2017","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1182\/blood-2019-126378","volume":"134","author":"Landgren","year":"2019","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.clml.2019.09.024","volume":"19","author":"Weisel","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood-2019-123170","volume":"134","author":"Costa","year":"2019","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1182\/blood-2018-09-874396","volume":"133","author":"Facon","year":"2019","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"LBA3","DOI":"10.1200\/JCO.2020.38.18_suppl.LBA3","volume":"38","author":"Kumar","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ajh.25435","volume":"94","author":"Forsberg","year":"2019","journal-title":"Am J Hematol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.3324\/haematol.2018.208272","volume":"104","author":"Bringhen","year":"2019","journal-title":"Haematologica"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Team AT. Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial. Lancet. 2013;381(9875):1391\u20131403. doi:10.1016\/S0140-6736(12)62198-9","DOI":"10.1016\/S0140-6736(12)62198-9"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1002\/cam4.2945","volume":"9","author":"Moreau","year":"2020","journal-title":"Cancer Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1182\/blood.2020005288","volume":"136","author":"Voorhees","year":"2020","journal-title":"Blood"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/bloodadvances.2019000010","volume":"3","author":"O\u2019dwyer","year":"2019","journal-title":"Blood Adv"},{"key":"ref43","volume-title":"Haematologica","year":"2017"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3324\/haematol.2018.191288","volume":"103","author":"Bringhen","year":"2018","journal-title":"Haematologica"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00277-020-04062-x","volume":"99","author":"Ball","year":"2020","journal-title":"Ann Hematol"},{"key":"ref46","volume":"6","author":"Moher","year":"2009"}],"container-title":["OncoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=74185","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=74185","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T12:11:33Z","timestamp":1633003893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/efficacy-and-toxicity-profile-ofcarfilzomib-based-regimens-for-treatme-peer-reviewed-fulltext-article-OTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":46,"URL":"https:\/\/doi.org\/10.2147\/ott.s317570","relation":{},"ISSN":["1178-6930"],"issn-type":[{"value":"1178-6930","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}